Authors: Wilson, Christopher M.; Ospina, Oscar E.; Townsend, Mary K.; Nguyen, Jonathan; Moran Segura, Carlos; Schildkraut, Joellen M.; Tworoger, Shelley S.; Peres, Lauren C.; Fridley, Brooke L.
Online: https://www.mdpi.com/2072-6694/13/12/3031
Issue: Cancers (Basel). 2021 Jun 17;13(12):3031.
Abstract
Immune modulation is considered a hallmark of cancer initiation and progression. The recent development of immunotherapies has ushered in a new era of cancer treatment. These therapeutics have led to revolutionary breakthroughs; however, the efficacy of immunotherapy has been modest and is often restricted to a subset of patients. Hence, identification of which cancer patients will benefit from immunotherapy is essential. Multiplex immunofluorescence (mIF) microscopy allows for the assessment and visualization of the tumor immune microenvironment (TIME). The data output following image and machine learning analyses for cell segmenting and phenotyping consists of the following information for each tumor sample: the number of positive cells for each marker and phenotype(s) of interest, number of total cells, percent of positive cells for each marker, and spatial locations for all measured cells. There are many challenges in the analysis of mIF data, including many tissue samples with zero positive cells or “zero-inflated” data, repeated measurements from multiple TMA cores or tissue slides per subject, and spatial analyses to determine the level of clustering and co-localization between the cell types in the TIME. In this review paper, we will discuss the challenges in the statistical analysis of mIF data and opportunities for further research.
